Citations

APA: Kandeil, A., Mostafa, A., Hegazy, R.R., El-Shesheny, R., El Taweel, A., Gomaa, M.R., Shehata, M., Elbaset, M.A., Kayed, A.E., Mahmoud, S.H., Moatasim, Y., Kutkat, O., Yassen, N.N., Shabana, M.E., GabAllah, M., Kamel, M.N., Abo Shama, N.M., El Sayes, M., Ahmed, A.N., Elalfy, Z.S., Mohamed, B.M., Abd . (Volume-, Issue- -(Year-2022)). Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. V accines.. Retrieved from https://doi.org/10.3390/vaccines9030214 Copy

Chicago: Kandeil, A., Mostafa, A., Hegazy, R.R., El-Shesheny, R., El Taweel, A., Gomaa, M.R., Shehata, M., Elbaset, M.A., Kayed, A.E., Mahmoud, S.H., Moatasim, Y., Kutkat, O., Yassen, N.N., Shabana, M.E., GabAllah, M., Kamel, M.N., Abo Shama, N.M., El Sayes, M., Ahmed, A.N., Elalfy, Z.S., Mohamed, B.M., Abd . "Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. V accines." Example, Volume--issue--Year-2022-2076-393X. https://doi.org/10.3390/vaccines9030214. Copy